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a b s t r a c t
Objective: Overlapping symptoms can make the diagnostic differentiation of attention-deﬁcit/hyper-
activity disorder (ADHD) and bipolar disorder (BD) challenging in adults using current clinical assess-
ments. This study sought to determine if current clinical measures delineate ADHD from BD in adults,
comparing relative levels of ADHD, BD and emotional lability (EL) symptoms.
Methods: Sixty adult women with ADHD, BD or controls were compared on self-report and interview
measures for ADHD symptoms, mania, depression, EL, and impairment.
Results: ADHD interview measures and self-ratings of ADHD symptoms best discriminated between
ADHD and BD. Self-report measures of EL and depression showed non-speciﬁc enhancement in both
clinical groups. BD-speciﬁc items may distinguish BD from ADHD if a retrospective time-frame is
adopted.
Conclusions: Using measures which capture speciﬁc symptoms of ADHD and chronicity/episodicity of
symptoms facilitates the delineation of ADHD from BD in adult women.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The diagnostic differentiation of attention-deﬁcit/hyperactivity
disorder (ADHD) from bipolar disorder (BD) is important for the
correct treatment and management of both conditions (Asherson
et al., 2014; Atmaca et al., 2009; Galanter et al., 2005; Mosholder
et al., 2009). Yet, similarities in symptoms such as restlessness,
increased production of speech and distractibility in both condi-
tions and evidence of persistent impulsive behaviours in euthymic
BD (Najt et al., 2007; Peluso et al., 2007) can make differentiation
of the two conditions challenging (Galanter and Leibenluft, 2008;
Kent and Craddock, 2003). The emerging evidence indicating high
levels of emotional lability (EL) in ADHD (Barkley and Fischer,
2010; Skirrow et al., 2014, 2012; Surman et al., 2013), independent
of comorbidity (Skirrow and Asherson, 2013), and the recognition
of EL as an associated feature of ADHD (American Psychiatric As-
sociation, 2013), further complicate the diagnostic boundaries
between ADHD and BD. In BD equivalent prevalence rates are
observed in both men and women (Diﬂorio and Jones, 2010), while
the ratio of males to females diagnosed with ADHD is 1.6:1
(Willcutt, 2012), with indications that ADHD persistence and
patterns of comorbidity are similar in both genders (Biederman
et al., 2011, 2012). However, it is acknowledged that there remains
a lack of research into ADHD in females, particularly amoung
adults (American Psychiatric Association, 2013).
Meta-analysis examining comorbidity of ADHD and BD in
adults identiﬁed rates ranging from 5% to 47% (Wingo and Ghaemi,
2007), and studies of familial co-variation indicate that the dis-
orders co-occur at a higher rate than in the general population,
suggesting a potential familial relationship between them (Larsson
et al., 2013; Skirrow et al., 2012). The existence of juvenile bipolar
disorder, now reconceptualised as severe mood dysregulation in
DSM-5, and its overlap with ADHD has been hotly debated (Kent
and Craddock, 2003; Skirrow et al., 2012). Yet, despite clearer di-
agnostic conceptualisations in adults, there are few studies com-
paring the extent to which symptoms are similar or different be-
tween ADHD and BD, and address the challenges of delineation in
adult populations. The few direct comparisons to date have used
self-report measures of ADHD and depression symptoms, which
may have limited scope in their potential to delineate the two
disorders (Ibanez et al., 2012; Torralva et al., 2011). The
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comparative degree and speciﬁcity of EL within each disorder is
also an important question to clarify, as mood ﬂuctuations are
seen as a characteristic feature of BD, and could result in the
misdiagnosis of adults with ADHD and high EL.
1.1. Aims of the study
The aims were to determine the potential of current clinical
measures to delineate ADHD from BD in adults, comparing relative
levels of ADHD, BD and EL symptoms across the two disorders.
Based on previous studies in men with ADHD we hypothesised
that EL frequently occurs in womenwith ADHD and for this reason
cross-sectional measures of EL will not distinguish between ADHD
and BD. We further hypothesise that women with ADHD will
present with a signiﬁcant number of ‘mania’ symptoms due to the
overlap in symptom criteria. We propose that the key distinction
to be made will be based on episodicity versus chronicity of the
symptoms and which might not be easy to determine based on
cross-sectional data alone.
2. Methods and materials
2.1. Sample
Participants with BD were recruited from a largely female
sample that had previously participated in another research study
(Hosang et al., 2012) and the Maudsley Psychosis Clinic. In ADHD,
population studies have not reported gender differences in clin-
ical-range symptoms (Das et al., 2012; de Zwaan et al., 2012), al-
though there remains a relatively limited amount of data collected
with adult female participants with ADHD. To address this need,
and for purposes of sample matching with the BD group, we re-
cruited an all-female sample in this study. Women with ADHD
were therefore recruited from the National Adult ADHD Clinic at
the Maudsley Hospital. Control participants were recruited from
the Mindsearch volunteer database maintained by the Institute of
Psychiatry, Psychology and Neuroscience, which comprises several
thousand potential participants. Participants were randomly se-
lected from all those meeting recruitment criteria for this study
(described below). In total 60 adult women were recruited (20
with ADHD, 20 with BD and 20 control participants). The study
received ethical approval by the Camberwell St Giles Research
Ethics Committee (Ref: 11/LO/0438) and was conducted according
to the Declaration of Helsinki. All participants provided informed
content.
2.2. Diagnosis and recruitment
Fifty-seven women with ADHD, 75 women with BD, and 120
control women matching requirements of age, gender and clinical
diagnosis based upon DSM-IV criteria were approached to partici-
pate. The ADHD participants met current criteria for combined-type
ADHD or inattentive-type ADHD with sufﬁcient past reported
symptoms of hyperactivity–impulsivity to have met combined-type
criteria during childhood. Participants in the BD group had a diag-
nosis of Bipolar I Disorder (BD-I) with evidence of a past manic
episode lasting one week or more. Eligibility to participate was
ascertained by checking medical records for details of diagnosis and
psychiatric history, with BD participants recruited via the BADGE
study having an additional conﬁrmation of diagnosis using The
Schedules for Clinical Assessment in Neuropsychiatry, Version 2.1
[SCAN] (Wing et al., 1990). Exclusions for all groups were drug or
alcohol dependency in the last six months, autism, epilepsy, neu-
rological disorders, brain injury, past ECT treatment, current in-
volvement in another research trial likely to alter symptomatology,
pregnancy or a limited proﬁciency in English language. Those with a
reported diagnosed comorbidity of both ADHD and BD at screening,
those currently experiencing a manic episode, or any ADHD parti-
cipants with a history of manic or hypo-manic episodes were ex-
cluded. Other comorbidities in the clinical groups were permitted.
This included one participant with comorbid Depression and one
with Obsessive Compulsive Disorder (OCD) in the ADHD group, and
one participant with comorbid Anxiety Disorder and one with
Borderline Personality Disorder (BPD) in the BD group. All primary
analyses were later re-run after excluding these individuals, to
check for the inﬂuence of these comorbidities on results. Control
participants reporting a history of psychiatric disorders or currently
taking medication at screening were excluded. Recruitment con-
tinued until 20 participants were recruited for each group, as this
was calculated to provide 80–90% power to detect a large effect size
(0.8) (Table 1). Samples were age-matched at a group level during
recruitment. ADHD participants were asked to stop stimulant
medication 48-h before research assessments. For ethical reasons,
BD participants were not asked to stop taking mood-stabilisers or
any anti-psychotic medication they had been prescribed. All parti-
cipants were asked to refrain from caffeinated drinks and nicotine
for two hours prior to the assessment session.
2.3. Procedure
Participants attended a single research session to complete
self-report measures and clinical interviews alongside other re-
search evaluations. All participants completed the same set of
assessments. For informant ratings, participants were given a
questionnaire to take home in a stamped address envelope, for a
family member or close friend to complete. Interview ratings were
conducted by an experienced researcher (GK), trained by a con-
sultant psychiatrist (PA) with experience of both ADHD and BD.
2.4. Measures
2.4.1. ADHD symptoms
Measures of ADHD symptoms were obtained using the 18-item
Barkley Adult ADHD Rating Scale (BAARS-IV) (Barkley and Murphy,
2006), which consists of the DSM-IV items related to inattention
and hyperactivity–impulsivity. Respondents indicated how fre-
quently they experienced behaviours on a scale of 0–3 (never or
Table 1
Number of participants recruited and reasons for exclusion.
ADHD BD Control
Number approached 57 75 120
Recruitment
Un-contactable 17 26 45
Declined 4 15 25
Travel or childcare difﬁculties 5 4 5
Did not attend or cancelled 1 1 13
Exclusions
Unsuitable diagnosis 3 7
ADHD with comorbid BD 4
Control with psychiatric disorder 8
Medical or neurological disorder 1 3
Autism 1
Past ECT treatment 1
Participating in another research trial 1
Currently pregnant 1
Insufﬁcient English language ability 1
Final Sample 20 20 20
Abbreviations: attention-deﬁcit/hyperactivity disorder (ADHD), Bipolar Disorder
(BD), Electroconvulsive therapy (ECT). An “unsuitable diagnosis” was a diagnosis of
BD-II (i.e. without a manic episode) in the BD group, or an inattentive-subtype
ADHD diagnosis with no evidence of symptoms of hyperactivity in childhood.
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rarely, sometimes, often, very often) during the past 6 months.
Total scores were calculated for each symptom dimension. The
Barkley’s functional impairment scale (Barkley and Murphy, 2006)
used the same scoring system and was included with the (BAARS-
IV) to create a third impairment subscale, indexing functional
impairments across several domains including occupational, daily
responsibilities and social relationships. Both self-rated and in-
formant-rated versions of the BAARS-IV were used to obtain
measures of ADHD symptoms.
The Diagnostic Interview for ADHD in Adults (DIVA) (Kooij and
Francken, 2007) was used to assess ADHD symptoms in partici-
pants. The DIVA, like the BAARS-IV, consists of 18 items used to
deﬁne the DSM-IV symptom criteria for ADHD, but is a semi-
structured interview conducted by a trained clinical investigator.
Each item is scored “yes”, if the behavioural symptom is present
often within the past 6 months. Outcomes were total current
ADHD symptom score, and separate totals for inattentive and hy-
peractive-impulsive symptom domains.
2.4.2. Mania and depression symptoms
The Beck's Depression Inventory II (DI) (Beck et al., 1996) was
included as a self-rated measure of depression symptoms. The
scale has 21 questions, rated 0–3 based on the severity of symp-
toms, during the past two weeks. The test variable was total score.
The self-report Altman Self-Rating Mania Scale (ASRM) (Altman
et al., 1997) was used to measure mania symptoms in the past
week. This is a 5-item measure scored 0–4 based on the strength
of the behaviour. The total score was used as the test variable.
A second measure of mania symptoms was collected using the
Young Mania Rating Scale (YMRS) (Young et al., 1978), completed
by the investigator following clinical interview. This 11-item
measure uses subjective report of mental phenomena and clinical
observations to rate behaviours associated with mania in the past
48 h. Seven items are scored 0–4 based on severity and the re-
maining four items (irritability, rate or amount of speech, delu-
sional/grandiose thought content, and severe aggressive or un-
controllable behaviour) are scored 0–8, as characteristic features of
manic episodes. For this study, a change indicator asking “Is this
how you normally feel?”, scored yes/no, was added to each item to
distinguish between episodic symptoms which are characteristic
of BD, and the more stable trait-like symptoms which are char-
acteristic of ADHD. A further question asking “Has there ever been a
time other than the last 48 h when you have felt…”, was added to
each of the 8 self-report items to count the number of symptoms
experienced in the past, including worst ever episode, to de-
termine the range of symptoms experienced by BD patients during
episodes of mania. Outcomes for this measure were total score,
number of present symptoms (excluding observer-rated items to
make this comparable with the past symptoms scale) and number
of past symptoms.
We also examined whether particular items on the YMRS,
which related to speciﬁc symptom domains or loaded on pre-
viously identiﬁed factors, were able to delineate the two clinical
groups. We compared two approaches. The ﬁrst approach was
based on diagnostic criteria for ADHD which grouped YMRS items
on whether they overlapped with ADHD symptoms (increased
motor activity/energy, increased rate of production of speech, and
language/thought disorder including distractible thought pro-
cesses and changing topics frequently); or did not overlap with
ADHD (inappropriate elevated mood, increased/inappropriate
sexual interest, delusions and grandiosity, and severe disruptive/
aggressive or uncontrollable behaviour); or are associated features
of ADHD that overlap with BD (difﬁculty sleeping and irritable
mood). The second approach used three groupings previously
identiﬁed by Hanwella and de Silva (2011) in a factor analysis of
YMRS items, which were labelled: irritable mania (increased
motor activity/energy, irritable moods, and severe disruptive/ag-
gressive or uncontrollable behaviour); elevated mania (elevated
mood, language/thought disorder, sexual interest and insight); and
psychotic mania (increased motor activity/energy, motor activity,
delusions and grandiosity, and appearance).
2.4.3. Emotional lability
The self-rated Affective Lability Scale Short Form (ALS-SF)
(Oliver and Simons, 2004), comprising of 18 items scored 1–4
(very un-descriptive, rather un-descriptive, rather descriptive,
very descriptive) was used as one of two measures of mood labi-
lity. The ALS-SF measures ﬂuctuations from a normal mood to
other emotional states from moment to moment during the past
week, and has been shown to comprise of three domains of an-
xiety–depression, depression–elation and anger (Oliver and Si-
mons, 2004). Total overall score and total score on each subscale
were used as the test variables.
The second measure of emotional lability was the auxiliary
subscale of the Centre for Neurologic Study-Lability Scale (CNS-LS)
(Moore et al., 1997), adapted by removing two items related to
impatience which have clear overlap with impulsive symptoms of
ADHD. This created a self-rated 8-item measure focusing on ne-
gative emotions, such as getting easily frustrated, upset and angry
occurring in the past month and past 5 years. Each item is scored
on a scale of 0–4 (applies never, rarely, occasionally, frequently,
most of the time), based on the frequency of each experience. Total
scores for the past month and past 5 years were used as the test
variables.
2.4.4. Intellectual ability
The Wechsler Abbreviated Scale of Intelligence Fourth Edition
(WASI-IV) (Wechsler, 1999) was administered to all participants to
derive an estimate of IQ.
2.4.5. Statistical analyses
Across the three samples, rating scale data were normally dis-
tributed for the BAARS-IV impairment scales (self-rated and in-
formant), the ALS total score and the hyperactive-impulsive sub-
scale of the DIVA. Otherwise, the most appropriate transforma-
tions were applied to the data (log or square-root). For the ALS and
YMRS subscales, no available transformations normalised the data,
so non-parametric Kruskal–Wallis tests were used. Group differ-
ences in normal and transformed-normal data were tested using
univariate ANOVAs. Where appropriate, pairwise comparisons
were conducted to discriminate which groups differed. On the
YMRS, the number of symptoms past and present were compared
using repeated-measures ANOVA to explore the interaction of
group and symptom change over time. Additional post-hoc pair-
wise comparisons were used to investigate both group differences
and differences between the number of past and presents symp-
toms within group. Analyses were carried out using STATA (Ver-
sion 11) and SPSS (Version 21). Given the large number of sub-
scales used in this study, and therefore high number statistical
comparisons and associated risk of type-I error, all reported p-
values were adjusted for multiple testing using family-wise Bon-
ferroni corrections to maintain α¼0.05 for all 20 independent
tests employed in the primary analysis and all subsequent post-
hoc comparisons.
3. Results
The groups did not differ in mean age (Mean (SD): ADHD¼37.4
(7.65); BD¼40.3 (7.68); Control¼36.7 (4.28); F¼1.63, p¼0.21) or
IQ (Mean (SD): ADHD¼104.5 (17.85); BD: 108 (12.50); Con-
trol¼112.35 (14.21); F¼1.37, p¼0.26). Mean scores on outcome
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measures with adjusted p-values are shown in Table 2 and the
standardised differences between groups for all measures are
shown in Fig. 1.
3.1. ADHD symptoms
Group differences were present for: DIVA total symptom score
(F(2,57)¼37.65, po0.001), inattention (F(2,57)¼33.68, po0.001)
and hyperactive-impulsive subscales (F(2,57)¼25.65, po0.001);
self-rated BAARS inattention (F(2,55)¼40.51, po0.001) and hy-
peractive-impulsive (F(2,57)¼18.39, po0.001) subscales; and in-
formant-rated BAARS inattention subscale (F(2,48)¼12.05,
p¼0.01). Post-hoc analysis indicated that both ADHD and BD
groups had higher ADHD symptom scores than controls on self
and informant reported ADHD rating scales. However, only the
ADHD group had higher current ADHD symptom scores compared
to controls when the DIVA interview was used as the measure of
ADHD symptoms.
The ADHD group had signiﬁcantly higher symptoms than the
BD group for the DIVA and self-rated BAARS scores, but not for the
informant-rated BAARS. To quantify the degree to which the DIVA
and self-rated BAARS scores can distinguish between patients with
ADHD and BD we calculated receiver operating characteristic
(ROC) scores. To compare the BAARS with the DIVA we made
binary variables from the BAARS scores for the absence (never,
rarely or sometimes) or presence (often, very often) of each in-
dividual ADHD item. The results are summarised in Table 3 with
optimal thresholds that balance sensitivity against speciﬁcity.
There was very good sensitivity (90%) and speciﬁcity (95%) for the
DIVA interview, particularly for the inattentive items when the
symptoms threshold of 6 or more symptoms was applied. This
compared to a much lower sensitivity of 65–70% using the BAARS,
although speciﬁcity remained high (95–100%).
3.2. Impairment
Ratings of impairment showed signiﬁcant group differences on
both self-rated (F(2,55)¼41.55, po0.001) and informant (F
(2,47)¼10.92, p¼0.003) scales. Both clinical groups reported ele-
vated impairment compared to controls on both scales. The ADHD
group had elevated scores compared to the BD group on the self-
report measure, but not the informant measure.
3.3. Mania and depression
Group differences in self-reported current manic symptoms on
the ASRM were not signiﬁcant (F(2,55)¼1.71, p¼1.00). Self-rated
current depression symptoms on the DI showed group differences
(F(2,57)¼13.79, po0.001), with both ADHD and BD groups re-
porting higher scores than controls, but not differing compared to
Table 2
Mean and standard deviations for ADHD and BD symptom measures and emotional lability measures.
Total n ADHD BD Controls Pairwise comparisons
ADHD-BD ADHD-control BD-control
Mean (SD) Mean (SD) Mean (SD) Adj. p Adj. p Adj. p
BAARS-IV self-rated
Inatt score 58 19.17 (6.22) 8.40 (4.39) 4.35 (2.91) o0.001*** o0.001*** 0.01**
Hyp-Imp score 60 15.75 (6.23) 7.75 (5.26) 5.55 (3.62) o0.001*** o0.001*** 0.38
Impairment score 58 19.58 (7.58) 10.00 (5.26) 2.85 (3.84) o0.001*** o0.001*** o0.001***
BAARS-IV informant
Inatt score 51 12.38 (5.67) 8.60 (5.63) 3.85 (3.53) 0.18 0.001*** 0.03*
Hyp-Imp score 51 9.94 (5.63) 7.07 (5.15) 4.90 (4.89) 0.34 0.02* 0.80
Impairment score 50 12.47 (7.51) 9.07 (6.35) 3.25 (3.92) 0.37 0.001*** 0.02*
DIVA
Total score 60 13.45 (3.02) 4.95 (3.27) 3.35 (2.96) o0.001*** o0.001*** 0.34
Inatt symptoms 60 7.55 (1.61) 2.95 (2.14) 1.65 (1.57) o0.001*** o0.001*** 0.10
Hyp-Imp symptoms 60 5.90 (2.36) 2.00 (2.03) 1.70 (1.78) o0.001*** o0.001*** 1.94
ASRM
Total score 58 4.63 (3.98) 4.95 (5.03) 2.42 (2.09) 2.66 0.31 0.39
YMRS
Total score 60 13.35 (7.35) 10.05 (8.06) 6.15 (5.68) 0.07 0.003** 0.74
No. current symptom 60 4.70 (2.03) 3.95 (2.28) 2.80 (1.91) 1.57 0.03** 0.82
No. past symptoms 60 4.60 (1.47) 7.10 (1.86) 2.35 (1.87) 0.03** o0.001*** o0.001***
State change (past 48 h) 60 2.05 (1.54) 2.75 (1.97) 1.70 (1.49) 1.08 1.49 0.11
DI
Total score 60 17.50 (14.54) 11.90 (11.11) 4.35 (4.03) 0.33 o0.001*** 0.003***
ALS-SF
Total score 60 41.35 (12.73) 35.65 (12.87) 24.50 (6.61) 0.33 o0.001*** 0.01**
Anxiety-depression score 60 11.50 (4.71) 10.15 (4.64) 7.25 (2.27) 0.70 0.01** 0.20
Elation-depression score 60 19.45 (5.17) 17.80 (7.05) 11.55 (3.79) 1.10 o0.001*** 0.01**
Anger score 58 10.61 (4.86) 7.70 (2.79) 5.70 (1.81) 0.11 o0.001*** 0.34
CNS
Past month score 59 15.79 (11.21) 7.45 (5.24) 3.60 (4.03) 0.03* o0.001*** 0.10
Past 5 year score 59 19.32 (11.34) 11.75 (6.09) 5.70 (3.67) 0.09 o0.001*** 0.03*
“Adj. p” family-wise Bonferroni corrected post-hoc p-values. “State change (past 48 h)” indexes manic-like symptom change in the past 48 h (appearing or disappearing).
Other abbreviations: Inattention (Inatt), Hyperactive-Impulsive (Hyp-Imp), Barkley Adult ADHD Rating Scale-IV (BAARS-IV), Diagnostic Interview for ADHD in Adults (DIVA),
Altman Self-Rating Mania Scale (ASRM), Young Mania Rating Scale (YMRS), Beck Depression Inventory (DI), Affective Lability Scale (ALS), Centre for Neurologic Study-Lability
Scale (CNS-LS).
*** po0.001.
** po0.01.
* po0.05.
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each another (Table 2).
The YRMS interview showed a nominal group difference in
total score for current symptoms (unadjusted p¼0.005), which did
not survive α-correction (F(2,59)¼5.78, p¼0.10). On the extension
questions added for this study, the groups did not differ in the
proportion of mania symptoms which had changed within the
past 48 h (F(2,57)¼1.31, p¼1.00). A repeated-measures ANOVA,
comparing the number of past symptoms with the number of
present symptoms, showed a signiﬁcant main effect of group (F
(2,57)¼6.88, po0.001), time period (F(1,57)¼15.56, p¼0.01) and
interaction of time period" group (F(2,57)¼12.03, po0.001).
Overall, post-hoc tests indicated that the BD group had a higher
number of mania symptoms in the past, but that the two clinical
groups did not differ in the number of current symptoms. The
ADHD group also showed more current mania symptoms than
controls, although BD-control differences were not signiﬁcant
(Table 2).
We further examined if subsets of items from the YMRS were
better able to discriminate ADHD from BD than the full measure,
based on symptom frequency (Table 4). The symptom-based
division of items only discriminated ADHD from BD using the non-
ADHD overlapping symptoms grouping (inappropriate elevated
mood, increased/inappropriate sexual interest, delusions and
grandiosity, and severe disruptive/aggressive or uncontrollable
behaviour) and then only for past ‘worst episode’ symptoms and
not current symptoms. Both clinical groups had elevated scores
compared to controls on the ADHD overlapping symptom group-
ing (increased motor activity/energy, increased rate of production
of speech, and language/thought disorder including distractible
thought processes and changing topics frequently) for both cur-
rent and past symptoms, but did not differ between themselves.
The shared associated symptom grouping (sleep disturbance and
irritability) indicated elevated scores for past symptoms in the BD
group compared to controls, but no differences for other com-
parisons. The factor-based item groupings did not show any group
differences for current symptoms. For past symptoms, on both
elevated mania (elevated mood, language/thought disorder, sexual
interest and insight) and psychotic mania (increased motor activ-
ity/energy, motor activity, delusions and grandiosity and appear-
ance) item groupings the BD group had elevated scores compared
to ADHD and controls. Additionally, on the psychotic mania cluster
the ADHD group had higher scores than controls. For irritable
mania items (increased motor activity/energy, irritable moods, and
severe disruptive/aggressive or uncontrollable behaviour) both
clinical groups scored higher than controls, but did not differ
compared to one another.
3.4. Emotional lability (EL)
Group differences were detected for ALS total scores (F(2,59)¼
11.86, p¼0.001), the elation-depression subscale (H(2)¼17.60,
po0.001) and the anger subscale (H(2)¼17.20, po0.001). Group
differences for the anxiety–depression subscale did not survive α-
correction (H(2)¼9.34, p¼0.18). Post-hoc pairwise comparisons
did not distinguish ADHD and BD groups on either total scores or
subscales (Table 2). The ADHD group had higher scores compared
to controls on all scales of the ALS, with the BD group showing
Fig. 1. Group differences on ADHD, mania, depression and emotional lability measures, as standardised scores with standard error.
Table 3
Receiver Operating Characteristics (ROC) scores showing sensitivity and speciﬁcity
of BAARS and DIVA measures to ADHD diagnosis compared to BD diagnosis.
ROC scores
AUC Threshold Sensitivity Speciﬁcity
BAARS inattention 0.87 6/9 0.70 0.95
BAARS hyper-imp 0.83 6/9 0.45 0.90
BAARS total score 0.89 11/18 0.65 1.00
DIVA inattention 0.95 7/9 0.90 0.95
DIVA hyper-imp 0.89 6/9 0.55 0.90
DIVA total score 0.97 11/18 0.90 0.95
Abbreviations: Barkley Adult ADHD Rating Scale (BAARS), Diagnostic Interview for
ADHD in Adults (DIVA), Area under the curve (AUC).
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higher scores than controls on total score and the elation-de-
pression subscale.
The CNS-LS, indicated group differences on both time spans
(last month: F(2,56)¼11.35, po0.001; last 5 years: F(2,56)¼12.04,
p¼0.001). For CNS-LS ratings of EL in the last month, the ADHD
group had elevated scores compared to both BD and controls, with
the BD group not differing from controls (Table 2). For ratings
based on worst ever in the last 5 years, both clinical groups had
higher scores than controls, but were undifferentiated compared
to each other.
3.5. Comorbidities
Primary analyses were rerun after excluding the four in-
dividuals which had a diagnosed comorbidity (ADHD: one de-
pression, one OCD; BD: one BPD, one Anxiety Disorder). Overall,
the results did not change with these participants excluded, except
for two post-hoc pairwise comparisons, which then became non-
signiﬁcant after correcting for multiple testing. These were the
ADHD-BD comparison on the CNS-LS (last month), where the
adjusted p-value became non-signiﬁcant (adj. p¼0.11, unadjusted
p¼0.04) and the ADHD-control comparison for the number of
present symptoms on the YMRS which weakened to a trend level
(adj. p¼0.07, unadjusted p¼0.008).
4. Discussion
In this study we investigated the similarities and differences
between female patients with typical ADHD, Bipolar I Disorder
(who were not currently experiencing a manic episode) and
healthy controls, using standard measures used in the diagnostic
assessment of ADHD and BD. Using ratings for the current mental
state, increased levels of ADHD and depression symptoms, emo-
tional lability and functional impairment were seen in both the
ADHD and BD groups compared to controls. The ADHD group
generally showed higher levels of psychopathology than the BD
group, particularly for current symptoms of emotional lability and
mania. Using retrospective ratings for mania on the YMRS, which
would measure past manic episodes, gave higher ratings in the BD
than the ADHD group, although both groups had higher ratings
than the controls. The DIVA interview was the best instrument for
separating out the two clinical groups, with high sensitivity and
speciﬁcity for ADHD. Overall, these ﬁndings show a signiﬁcant
level of residual symptoms and impairments in BD patients during
non-manic periods, which was similar to the ADHD patients for
depression and impairment, but did not reach the levels of ADHD,
mania and emotional lability symptoms seen in the ADHD group.
4.1. Distinguishing BD from ADHD
Making this distinction is important because BD patients often
present with continued mood symptoms and functional impair-
ments in between major affective episodes, raising the question of
whether any observed psychopathology is due to persistence of BD
or could be due to comorbid ADHD. Indeed this study showed
considerable overlap between BD and ADHD using both rating
scale and interview measures. Yet it was possible to distinguish
between the ADHD and BD groups. We found that the interview
measure for current ADHD symptoms provided very good sensi-
tivity (around 90%) and speciﬁcity (around 95%) to identify ADHD
in comparison with BD. In contrast, the self-reported ADHD
measures showed enhancement of scores in both clinical groups,
although self-ratings of ADHD inattention were moderately good
at separating ADHD from BD. For BD the best discrimination came
from the use of the YMRS mania interview, which was sensitive to
Table 4
Young Mania Rating Scale (YMRS), a comparison of different item groupings to delineate ADHD from bipolar disorder.
Kruskal–Wallis Pairwise Comparisons
H Adj. p ADHD-BD ADHD-control BD-control
Adj. p Adj. p Adj. p
A) Current number of symptoms
Symptoms based
ADHD overlapping 17.27 o0.001*** 0.32 o0.001*** 0.04*
ADHD non-overlapping 0.21 1 – – –
Shared ADHD associated 9.14 0.12 – – –
Factor based
F1. Irritable mania 8.68 0.16 – – –
F2. Elevated mania 5.25 0.86 – – –
F3. Psychotic mania 4.94 1 – – –
B) Past number of symptoms
Symptoms based
ADHD overlapping 27.33 o0.001*** 0.98 o0.001*** o0.001***
ADHD non-overlapping 31.54 o0.001*** o0.001*** 1 o0.001***
Shared ADHD associated 18.21 o0.001*** 0.13 0.09 o0.001***
Factor based
F1. Irritable mania 24.64 o0.001*** 1 o0.001*** o0.001***
F2. Elevated mania 19.29 o0.001*** 0.006*** 0.67 o0.001***
F3. Psychotic mania 32.89 o0.001*** 0.02* 0.02* o0.001***
**po0.01. “Adj. p” batchwise Bonferroni corrected post-hoc p-values. Symptom-based item groupings consisted of the following items: ADHD overlapping (increased motor
activity/energy, increased rate of production of speech, and language/thought disorder including distractible thought processes and changing topics frequently), ADHD non-
overlapping (inappropriate elevated mood, increased/inappropriate sexual interest, delusions and grandiosity, and severe disruptive/aggressive or uncontrollable behaviour),
and shared ADHD associated symptoms (difﬁculty sleeping and irritable moods). Factor-analysis based item groupings consisted of the following items: irritable (increased
motor activity/energy, irritable moods, and severe disruptive/aggressive or uncontrollable behaviour), elevated mania (elevated mood, language/thought disorder, sexual
interest and insight), and psychotic mania (increased motor activity/energy, motor activity, delusions and grandiosity and appearance).
* po0.05
*** po0.001.
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differences between ADHD and BD groups when using a retro-
spective ‘worst ever’ adaption included for this study. However,
even using retrospective data, the ADHD group showed a sig-
niﬁcant level of symptoms on the YMRS, and for current symp-
toms the ADHD group had more mania symptoms than the BD
group. These ﬁndings are similar to those reported in previous
studies.
For the ADHD measures, the inattentive symptoms gave the
best discrimination of ADHD from BD for both the self-rated and
interview measure. This is similar to the results of Ibanez et al.
(2012), who report higher self-rated inattention scores in ADHD
compared to BD or control groups using the same self-rated scale
of ADHD used in this study, although they did not observe a sig-
niﬁcant BD-control difference.
The Altman Self-Rating Mania Scale (ASRM) and the Beck De-
pression Inventory (DI) were not able to distinguish the two
clinical disorders. High depression scores for both clinical groups
highlight that symptoms of depression are commonly seen in
ADHD. This replicates ﬁndings from Torralva et al. (2011) and
Ibanez et al. (2012) of elevated depression scores on the DI in
ADHD compared to BD.
Current symptom score and number of current symptoms on
the YMRS mania interview showed that the ADHD group had
higher levels of mania-like symptoms compared to both the con-
trols and the BD group. These results, collected using the standard
form of the measure, highlight the potential difﬁculties of deli-
neating ADHD and BD using cross-sectional (present state) mania
measures, and replicate ﬁndings for Ibanez et al. (2012), which
reported higher mania symptom scores in the ADHD group com-
pared to controls on this measure. In contrast, when the scale was
applied to the number of past symptoms, the BD group had a
greater number of mania symptoms than the ADHD or control
groups, even though the ADHD continued to report higher past
symptoms than controls. These ﬁndings in combination indicate
two important points. Firstly, that the YMRS may only be effective
at distinguishing ADHD and BD when comparing retrospective
worst episode information, meaning that enquiring about histor-
ical manic episodes, and especially symptoms known not to not
overlap with ADHD such as grandiosity and increased sex drive
(Skirrow et al., 2012), may assist clinicians in delineating ADHD
from BD. Secondly, that the YMRS should not be used exclusively
to make a diagnosis of BD, as other conditions, such as ADHD, also
score highly on this scale.
Overall, these ﬁndings illustrate the considerable overlap of
symptoms in ADHD and BD. We found greater speciﬁcity for the
ADHD symptoms elicited at interview to correctly identify the
ADHD group, than for the traditional BD symptoms to correctly
separate BD from ADHD. Thus the two disorders can usually be
distinguished through a combination of detailed symptom review,
elicited using a clinical interview, with a consideration of the time
course and episodicity of the symptoms that are present. These
data are consistent with other literature showing mood symptoms
and EL are commonly seen in ADHD (Posner et al., 2014; Shaw
et al., 2014; Skirrow and Asherson, 2013; Skirrow et al., 2014), and
illustrate the importance of considering ADHD as a differential
diagnosis in patients presenting with chronic (non-episodic and
trait-like) mood symptoms, including symptoms of mania, de-
pression and emotional lability, alongside other chronic, non-epi-
sodic, trait-like psychiatric conditions, including borderline per-
sonality disorder, cyclothymia and dysthymia. Therefore, a devel-
opmental account including age of onset and course (chronic
versus episodic) should always be used to establish the diagnosis,
and for an episode of mania/hypomania there must be evidence of
a change from the premorbid mental state.
4.2. YMRS symptom clusters
We completed further exploratory analyses to investigate
whether particular YMRS items might be speciﬁcally associated
with either ADHD or BD. We compared a three-cluster DSM
symptom model (ADHD overlap; no-overlap; mood and sleep
problems) against an empirically-derived three-factor model (ir-
ritable mania; elevated mania; psychotic mania) identiﬁed by
Hanwella and de Silva (2011). For current symptom scores, group
differences were only found on the ADHD overlapping symptoms
item grouping, consisting of increased motor activity/energy, in-
creased rate of production of speech and language/thought dis-
order items, where both clinical groups scored signiﬁcantly higher
than controls. No other differences were found for the symptom-
based or factor-based model. In line with our other analysis, this
implies that the YMRS is poor at distinguishing ADHD and BD
outside of a manic episode in its standard form.
For the number of past symptoms, based onworst ever episode,
more differences emerged due to the higher number of symptoms
reported by the BD group during past manic episodes. For the
overlapping symptom grouping from the symptom-based model,
and the irritable mania grouping from the factor-based model,
both clinical groups had high scores compared to controls, in-
dicating that these clusters both capture shared symptoms. How-
ever, only the elevated motor activity item was common between
them (overlapping items: motor activity, speech rate, language/
thought disorder; irritable mania: motor activity, irritability, dis-
ruptive/aggressive behaviour). Scores on item groupings for over-
lapping symptoms, mood, elevated mania and psychotic mania were
all higher for the BD group, compared to both ADHD and control
groups.
Overall, these preliminary ﬁndings suggest that ADHD and BD
might load separately on speciﬁc items within the YMRS, and
therefore development of a subscale designed to delineate ADHD
from euthymic BD in adults may be possible. However, as in-
dicated by our ﬁndings, any measure will require a retrospective
component to fully delineate ADHD from BD.
4.3. Chronicity and validity of symptom measurement
The interview measures provided better discrimination be-
tween ADHD and BD. One reason for this is likely to be that an
interviewer is able to explore both the nature and time course of
symptoms during an interview, to ensure any reported symptoms
meet the question criteria. The DIVA measure provides several
examples of behaviours associated with each symptom, allowing
the interviewer to qualitatively explore each symptom before
rating as present or absent. In contrast, the self-report measures
only provide a question, but no examples and rely on the inter-
pretation of an untrained person. This means that it is unknown if
the items are being scored based on equivalent symptoms, as well
as severity of symptoms, within each clinical group. In terms of the
time course, the wording in the rating scales is also more ambig-
uous. For example, the DIVA interview items are scored when
symptoms are present for at least six months or more. Although to
a lesser extent this is also true of the self-report ADHD measures,
the wording of questions is more ambiguous, stating that symp-
toms should be present during the last six months. These ratings
could therefore reﬂect symptoms of any duration during this
period, rather than the sustained trait-like symptoms that char-
acterise ADHD.
The YMRS, on the other hand, is designed speciﬁcally to eval-
uate manic symptoms in a short-time window (past 48 h). Al-
though our ﬁndings suggest that this measure would be effective
at delineating ADHD from BD as a retrospective measure, or during
a BD manic episode, it was not effective at delineating ADHD from
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BD outside of a manic episode based on current symptoms alone.
The YMRS therefore has discriminatory potential, and could be
adapted either through development of a speciﬁc subscale using
items which load selectively onto one of the clinical disorders, or
by adapting the measure to compare the episodicity of symptoms;
thereby making the distinction between chronic trait symptoms of
ADHD from the episodic symptoms of BD. Our ﬁndings support
arguments that chronicity versus episodicity is a key delineating
factor between ADHD and BD in adulthood (Skirrow et al., 2012).
4.4. Emotional lability (EL)
EL is associated with both ADHD (Skirrow and Asherson, 2013)
and euthymic BD (Judd et al., 2003). Our study supports the view
of EL as a largely non-speciﬁc set of symptoms that are seen across
different disorders, with high EL scores seen in both the ADHD and
BD groups compared to controls. Indeed, EL occurred at higher rate
in the ADHD patients, consistent with the emerging view of EL as
an associated feature of ADHD. EL cannot therefore be relied upon
to discriminate ADHD from BD. For this reason the current absence
of EL from the DSM-5 ADHD criteria, but its inclusion as a char-
acteristic feature of ADHD that supports the diagnosis of ADHD,
remains a sensible decision (American Psychiatric Association,
2013). Health care professionals need to be reminded that the
classiﬁcation systems are not designed to capture all aspects of a
clinical condition, but to provide an optimal algorithm that helps
to separate one condition from another. In this regard, the DSM-5
ADHD items appear to be more speciﬁc to ADHD than the DSM-5
BD items are to BD (particularly if the deﬁnition of BD symptoms
reﬂecting a change from the pre-morbid mental state is ignored).
4.5. Impairment ratings
ADHD participants showed more functional impairments than
BD and controls, yet the BD group also showed higher levels of
impairment compared to controls. This suggests that while im-
pairment is known to be present in both disorders (Brassett-Har-
knett and Butler, 2007; Samalin et al., 2014), women with ADHD
may be more severely impaired than women with BD who are not
experiencing a manic episode. Studies into the individual dis-
orders indicate that people with BD may show normal pre-morbid
functioning (Reichenberg et al., 2002), while ADHD is associated
with chronic functional impairment throughout lifespan (Brassett-
Harknett and Butler, 2007; Lin et al., 2015). However, to date, there
is insufﬁcient cross-disorder evidence to determine if differences
in psychosocial impairment between ADHD and BD represent a
potentially useful marker for delineation.
4.6. Limitations and future directions
The samples are relatively small, consisting of selected patients
with typical ADHD, typical BD-I and healthy controls, and focuses
only on female participants. It is therefore not clear the extent to
which these ﬁndings will generalise to more complex patients, of
both genders, showing features of both ADHD and BD. ADHD is
considered to reﬂect the extreme and impairing tail of a dimen-
sional trait and symptoms commonly may also occur at sub-di-
agnostic levels (Hudziak et al., 1999; Simon et al., 2009). This
means that BD patients are expected to display some ADHD traits
as part of a normal population distribution. However, we were
unable to determine if the elevated ADHD symptoms in our BD
sample represent a manifestation of BD or an independent sub-
clinical expression of ADHD. The use of structured clinical inter-
views during research assessments, in addition to the symptom
measures presented here,may have clariﬁed matters further. In
future, replication using prospective approaches, and structured
clinical interviews, would be useful to determine if the develop-
ment of a subscale based on item grouping in the YMRS has
clinical utility for delineating ADHD from BD.
This study also focused on the most characteristic forms of
ADHD and BD, in order to recruit homogeneous samples where
the distinction in primary diagnosis was entirely clear. However,
replication in clinical samples that are less highly selected and
therefore closer to clinical realities would further enhance the
usefulness of this research, as determining the potential for mis-
diagnosis between ADHD and BD under a broader range of con-
ditions would be informative from a clinical perspective. For in-
stance, delineation may be easier during manic episodes where BD
symptoms are greatly pronounced, and may be more challenging
in comparisons with BD-II and cyclothymia where reduced
symptom severity will likely make the clinical differentiation of
symptoms more difﬁcult.
5. Conclusions
Overall, we show that ADHD is a chronic, impairing disorder,
with a high degree of EL and hyperactivity which could be con-
fused with symptoms of mania. Measures such as the DIVA in-
terview which combine both a detailed disorder speciﬁc descrip-
tion of ADHD symptoms with a temporal component that captures
the distinction between sustained traits and episodic symptoms
that reﬂect a change in the pre-morbid mental state are best at
discriminating ADHD from BD in adult women. We therefore
conclude that interview measures combined with a develop-
mental account of symptoms and impairments provide good dis-
crimination compared to rating scale data, and should always be
used as the primary diagnostic tool.
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